- Home
- AMRX vs CPRX Comparison
AMRX vs CPRX Comparison
Compare AMRX & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- CPRX
- Stock Information
- Founded
- AMRX 2002
- CPRX 2002
- Country
- AMRX United States
- CPRX United States
- Employees
- AMRX N/A
- CPRX N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMRX Health Care
- CPRX Health Care
- Exchange
- AMRX Nasdaq
- CPRX Nasdaq
- Market Cap
- AMRX 2.4B
- CPRX 2.9B
- IPO Year
- AMRX N/A
- CPRX 2006
- Fundamental
- Price
- AMRX $7.41
- CPRX $23.37
- Analyst Decision
- AMRX Strong Buy
- CPRX Strong Buy
- Analyst Count
- AMRX 5
- CPRX 7
- Target Price
- AMRX $10.80
- CPRX $32.29
- AVG Volume (30 Days)
- AMRX 2.1M
- CPRX 975.9K
- Earning Date
- AMRX 05-02-2025
- CPRX 05-07-2025
- Dividend Yield
- AMRX N/A
- CPRX N/A
- EPS Growth
- AMRX N/A
- CPRX 178.13
- EPS
- AMRX N/A
- CPRX 1.57
- Revenue
- AMRX $2,830,186,000.00
- CPRX $534,645,999.00
- Revenue This Year
- AMRX $10.49
- CPRX $15.59
- Revenue Next Year
- AMRX $7.00
- CPRX $8.90
- P/E Ratio
- AMRX N/A
- CPRX $14.90
- Revenue Growth
- AMRX 13.42
- CPRX 29.97
- 52 Week Low
- AMRX $5.18
- CPRX $14.47
- 52 Week High
- AMRX $9.48
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- AMRX 46.13
- CPRX 50.33
- Support Level
- AMRX $7.15
- CPRX $20.80
- Resistance Level
- AMRX $8.02
- CPRX $25.01
- Average True Range (ATR)
- AMRX 0.32
- CPRX 0.83
- MACD
- AMRX 0.02
- CPRX -0.06
- Stochastic Oscillator
- AMRX 31.07
- CPRX 61.05
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).